VIRAX IMMUNE
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Feb 2032: the §8 declaration of use).
Record
- Serial number
- 98042452
- Registration number
- 8128713
- Mark type
- Word mark
- Filed
- 14 Jun 2023
- Published for opposition
- 10 Dec 2024
- Registered
- 03 Feb 2026
- Next maintenance filing
- §8 declaration of use, due by 03 Feb 2032 (grace period to 03 Aug 2032)
- Attorney of record
- David W. Grace
Goods and services
- Class 005 — Pharmaceuticals: Specimen collection kits for use in virus testing, namely, test kits for professional use comprised primarily of medical diagnostic reagents and assays and also including assay microplates used in diagnosis and assessment of adoptive immunity and post viral syndromes
Owner
- VIRAX BIOLABS (UK) LIMITED, London, GB
- VIRAX BIOLABS (UK) LIMITED, London, GB
- VIRAX BIOLABS (UK) LIMITED, London, GB
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jun 2025 — USE AMENDMENT FILED
- 28 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE